Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizaveta V Starikova

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Environmental Microbiology|July 18, 2018
ACI-1 beta-lactamase is widespread across human gut microbiomes in Negativicutes due to transposons harboured by tailed prophagesChris M Rands, Elizaveta V Starikova, Harald Brüssow, et al.
Bioinformatics (Oxford, England)|April 21, 2020
Phigaro: high-throughput prophage sequence annotationElizaveta V Starikova, Polina O Tikhonova, Nikita A Prianichnikov, et al.
Microorganisms|August 6, 2020
A Cross-Sectional Study of the Gut Microbiota Composition in Moscow Long-LiversDaria A Kashtanova, Nataliya S Klimenko, Irina D Strazhesko, et al.
Bioinformatics (Oxford, England)|March 3, 2019
VERA: agent-based modeling transmission of antibiotic resistance between human pathogens and gut microbiotaOksana E Glushchenko, Nikita A Prianichnikov, Evgenii I Olekhnovich, et al.
Frontiers in Microbiomes|March 19, 2026
Microbial communities of the upper respiratory tract in mild and severe COVID-19 patients: a possible link with the disease courseJulia S Galeeva, Elizaveta V Starikova, Dmitry E Fedorov, et al.
Data in Brief|December 23, 2017
Draft genomes of <i>Enterococcus faecium</i> strains isolated from human feces before and after eradication therapy against <i>Helicobacter pylori</i>Nikita A Prianichnikov, Maja V Malakhova, Vlad V Babenko, et al.
Frontiers in Microbiology|September 12, 2019
Shifts in the Human Gut Microbiota Structure Caused by Quadruple <i>Helicobacter pylori</i> Eradication TherapyEvgenii I Olekhnovich, Alexander I Manolov, Andrey E Samoilov, et al.
Biomedicines|May 25, 2024
Microbial Signatures in COVID-19: Distinguishing Mild and Severe Disease via Gut MicrobiotaJulia S Galeeva, Dmitry E Fedorov, Elizaveta V Starikova, et al.
Iscience|December 6, 2024
Oropharyngeal resistome remains stable during COVID-19 therapy, while fecal resistome shifts toward a less diverse resistotypeElizaveta V Starikova, Yulia S Galeeva, Dmitry E Fedorov, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Environmental Microbiology|July 18, 2018
ACI-1 beta-lactamase is widespread across human gut microbiomes in Negativicutes due to transposons harboured by tailed prophagesChris M Rands, Elizaveta V Starikova, Harald Brüssow, et al.
Bioinformatics (Oxford, England)|April 21, 2020
Phigaro: high-throughput prophage sequence annotationElizaveta V Starikova, Polina O Tikhonova, Nikita A Prianichnikov, et al.
Microorganisms|August 6, 2020
A Cross-Sectional Study of the Gut Microbiota Composition in Moscow Long-LiversDaria A Kashtanova, Nataliya S Klimenko, Irina D Strazhesko, et al.
Bioinformatics (Oxford, England)|March 3, 2019
VERA: agent-based modeling transmission of antibiotic resistance between human pathogens and gut microbiotaOksana E Glushchenko, Nikita A Prianichnikov, Evgenii I Olekhnovich, et al.
Frontiers in Microbiomes|March 19, 2026
Microbial communities of the upper respiratory tract in mild and severe COVID-19 patients: a possible link with the disease courseJulia S Galeeva, Elizaveta V Starikova, Dmitry E Fedorov, et al.
Data in Brief|December 23, 2017
Draft genomes of <i>Enterococcus faecium</i> strains isolated from human feces before and after eradication therapy against <i>Helicobacter pylori</i>Nikita A Prianichnikov, Maja V Malakhova, Vlad V Babenko, et al.
Frontiers in Microbiology|September 12, 2019
Shifts in the Human Gut Microbiota Structure Caused by Quadruple <i>Helicobacter pylori</i> Eradication TherapyEvgenii I Olekhnovich, Alexander I Manolov, Andrey E Samoilov, et al.
Biomedicines|May 25, 2024
Microbial Signatures in COVID-19: Distinguishing Mild and Severe Disease via Gut MicrobiotaJulia S Galeeva, Dmitry E Fedorov, Elizaveta V Starikova, et al.
Iscience|December 6, 2024
Oropharyngeal resistome remains stable during COVID-19 therapy, while fecal resistome shifts toward a less diverse resistotypeElizaveta V Starikova, Yulia S Galeeva, Dmitry E Fedorov, et al.
Pageof 1